- Investing Ideas
- Swedish Pharmaceuticals & Biotech Most Popular Stocks
Swedish Pharmaceuticals & Biotech Most Popular Stocks
Results
89
Most Popular Stocks on the market
89 companies
Swedish Orphan Biovitrum
Market Cap: SEK 155.6b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 447.00
7D
-0.3%
1Y
58.7%
Camurus
Market Cap: SEK 35.9b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 604.00
7D
1.7%
1Y
-13.4%
BioArctic
Market Cap: SEK 28.5b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 321.00
7D
-1.4%
1Y
12.4%
AddLife
Market Cap: SEK 19.8b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 162.70
7D
3.8%
1Y
-14.1%
Bonesupport Holding
Market Cap: SEK 13.8b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 210.20
7D
-5.1%
1Y
-28.9%
Vitrolife
Market Cap: SEK 12.4b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 91.50
7D
1.3%
1Y
-29.9%
BioGaia
Market Cap: SEK 11.1b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 110.00
7D
2.5%
1Y
-0.3%
Hansa Biopharma
Market Cap: SEK 3.7b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 36.62
7D
-7.9%
1Y
8.8%
Egetis Therapeutics
Market Cap: SEK 3.7b
A pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally.
EGTX
SEK 7.91
7D
-0.6%
1Y
40.0%
Swedencare
Market Cap: SEK 3.5b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 22.00
7D
-1.6%
1Y
-34.5%
Vicore Pharma Holding
Market Cap: SEK 2.8b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 10.10
7D
-4.7%
1Y
0%
BICO Group
Market Cap: SEK 1.6b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 22.25
7D
8.5%
1Y
3.2%
Flerie
Market Cap: SEK 1.5b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 17.50
7D
-2.8%
1Y
-51.5%
BioInvent International
Market Cap: SEK 1.5b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.
BINV
SEK 22.35
7D
0%
1Y
-24.7%
Cereno Scientific
Market Cap: SEK 1.4b
A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden.
CRNO B
SEK 4.46
7D
-1.8%
1Y
-46.6%
Saniona
Market Cap: SEK 1.4b
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 10.00
7D
-1.3%
1Y
-18.6%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 20.00
7D
-0.5%
1Y
-11.9%
AlzeCure Pharma
Market Cap: SEK 1.1b
Operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 7.74
7D
-5.4%
1Y
168.8%
Medivir
Market Cap: SEK 1.1b
A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.
MVIR
SEK 1.70
7D
-4.1%
1Y
9.7%
SynAct Pharma
Market Cap: SEK 1.0b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 17.96
7D
-3.5%
1Y
-9.4%
Devyser Diagnostics
Market Cap: SEK 903.6m
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 53.50
7D
-2.6%
1Y
-65.4%
Infant Bacterial Therapeutics
Market Cap: SEK 875.6m
Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.
IBT B
SEK 65.00
7D
0%
1Y
-8.2%
Oncopeptides
Market Cap: SEK 816.7m
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 2.07
7D
27.5%
1Y
-57.1%
Dicot Pharma
Market Cap: SEK 805.4m
Engages in the development of pharmaceutical products in Sweden.
DICOT
SEK 0.23
7D
-4.2%
1Y
-72.9%
Hamlet BioPharma
Market Cap: SEK 746.3m
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
HAMLET B
SEK 4.20
7D
14.3%
1Y
1.4%
Curasight
Market Cap: DKK 478.8m
Develops therapeutic and diagnostic solutions for the treatment of cancer.
CURAS
DKK 9.68
7D
-3.2%
1Y
101.7%
FluoGuide
Market Cap: SEK 572.2m
A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.
FLUO
SEK 35.00
7D
3.9%
1Y
-6.4%
Cinclus Pharma Holding
Market Cap: SEK 535.2m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 11.50
7D
-3.0%
1Y
-33.4%
Moberg Pharma
Market Cap: SEK 511.4m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 10.84
7D
-2.3%
1Y
23.3%
Orexo
Market Cap: SEK 447.0m
A pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 12.80
7D
-1.8%
1Y
-54.9%
Xspray Pharma
Market Cap: SEK 442.9m
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 9.34
7D
-0.1%
1Y
-82.0%
Enzymatica
Market Cap: SEK 435.7m
A life science company, develops and sells medical devices for infectious diseases.
ENZY
SEK 1.80
7D
-8.9%
1Y
-23.6%
Mendus
Market Cap: SEK 428.4m
A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.
IMMU
SEK 6.46
7D
-6.0%
1Y
-10.3%
Cantargia
Market Cap: SEK 390.1m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 1.57
7D
-1.4%
1Y
-43.5%
Corline Biomedical
Market Cap: SEK 371.1m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.
CLBIO
SEK 14.20
7D
-9.6%
1Y
-2.7%
Intervacc
Market Cap: SEK 344.2m
Develops novel veterinary vaccines for animals in Sweden.
IVACC
SEK 1.01
7D
4.4%
1Y
-2.7%